<DOC>
	<DOCNO>NCT00691717</DOCNO>
	<brief_summary>The purpose study evaluate safety intraocular-lowering efficacy anecortave acetate depot administer anterior juxtascleral depot ( AJD ) treatment elevate intraocular pressure ( IOP ) patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Anecortave Acetate Safety Patients With Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Patients 18 year age old openangle glaucoma ( without pigment dispersion pseudoexfoliation ) ocular hypertension . Other protocoldefined inclusion criterion may apply . Patients form glaucoma openangle . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Anecortave acetate</keyword>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>IOP</keyword>
	<keyword>OHT</keyword>
</DOC>